Cardinal Health 2029 remained flat by 0.0% to $327.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 27.7%, from $256.00M to $327.00M. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests a higher concentration of intangible assets reaching their amortization phase in this period.
The projected amortization expense for finite-lived intangible assets specifically for the fiscal year 2029. This reflec...
Commonly reported in the notes to financial statements for firms with historical acquisition activity.
other_finite_lived_intangible_assets_amortization_expens_a9462e| Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $238.00M | $237.00M | $235.00M | $206.00M | $208.00M | $209.00M | $173.00M | $174.00M | $213.00M | $191.00M | $213.00M | $256.00M | $307.00M | $327.00M | $327.00M |
| QoQ Change | — | -0.4% | -0.8% | -12.3% | +1.0% | +0.5% | -17.2% | +0.6% | +22.4% | -10.3% | +11.5% | +20.2% | +19.9% | +6.5% | +0.0% |
| YoY Change | — | — | — | -13.4% | -12.2% | -11.1% | -16.0% | -16.3% | +1.9% | +10.4% | +22.4% | +20.2% | +60.7% | +53.5% | +27.7% |